Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $115,900 | 9 | 95.5% |
| Travel and Lodging | $3,897 | 5 | 3.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,580 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $78,364 | 9 | $0 (2022) |
| Genentech USA, Inc. | $37,883 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $4,050 | 2 | $0 (2017) |
| Vertex Pharmaceuticals Incorporated | $1,080 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,227 | 2 | Genentech USA, Inc. ($13,227) |
| 2023 | $25,736 | 3 | Genentech USA, Inc. ($24,656) |
| 2022 | $22,000 | 1 | Genentech, Inc. ($22,000) |
| 2021 | $25,000 | 2 | Genentech, Inc. ($25,000) |
| 2020 | $10,000 | 1 | Genentech, Inc. ($10,000) |
| 2019 | $10,239 | 2 | Genentech, Inc. ($10,239) |
| 2018 | $11,125 | 3 | Genentech, Inc. ($11,125) |
| 2017 | $4,050 | 2 | Merck Sharp & Dohme Corporation ($4,050) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $227.38 | General |
| 04/15/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $13,000.00 | General |
| 09/19/2023 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $22,000.00 | General |
| 09/19/2023 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $2,655.65 | General |
| 04/19/2023 | Vertex Pharmaceuticals Incorporated | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,080.00 | General |
| 08/23/2022 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $22,000.00 | General |
| 08/11/2021 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $22,000.00 | General |
| 08/11/2021 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 06/10/2020 | Genentech, Inc. | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: None | ||||||
| 12/19/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: None | ||||||
| 12/19/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Travel and Lodging | Cash or cash equivalent | $238.65 | General |
| Category: None | ||||||
| 06/04/2018 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 06/04/2018 | Genentech, Inc. | — | Travel and Lodging | Cash or cash equivalent | $625.07 | General |
| 03/08/2018 | Genentech, Inc. | Non-Covered Product (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: None | ||||||
| 01/04/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| 01/04/2017 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 50 | 136 | $106,134 | $21,755 |
| 2022 | 2 | 45 | 90 | $64,344 | $13,869 |
| 2021 | 4 | 106 | 222 | $136,678 | $28,812 |
| 2020 | 4 | 83 | 167 | $111,811 | $24,207 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 103 | $90,786 | $18,430 | 20.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 33 | $15,348 | $3,325 | 21.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 61 | $52,523 | $11,329 | 21.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 29 | $11,821 | $2,540 | 21.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 43 | 117 | $103,857 | $21,969 | 21.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 53 | $15,635 | $3,296 | 21.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 34 | $14,306 | $2,950 | 20.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 18 | $2,880 | $597.06 | 20.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 36 | 104 | $92,488 | $20,025 | 21.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 23 | 27 | $11,255 | $2,451 | 21.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 18 | $5,242 | $1,123 | 21.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 18 | $2,826 | $607.86 | 21.5% |
About Dr. Deborah Hung, MD
Dr. Deborah Hung, MD is a Infectious Disease healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629068267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deborah Hung, MD has received a total of $121,377 in payments from pharmaceutical and medical device companies, with $13,227 received in 2024. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($115,900).
As a Medicare-enrolled provider, Hung has provided services to 284 Medicare beneficiaries, totaling 615 services with total Medicare billing of $88,643. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Boston, MA
- Active Since 10/25/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1629068267
Products in Payments
- Non-Covered Product (Drug) $20,739
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Boston
Dr. Nesli Basgoz, Md, MD
Infectious Disease — Payments: $1.9M
Yoav Golan, M.d, M.D
Infectious Disease — Payments: $1.6M
Todd Ellerin, M.d, M.D
Infectious Disease — Payments: $937,891
Paul Sax, Md, MD
Infectious Disease — Payments: $425,107
David Snydman, Md, MD
Infectious Disease — Payments: $172,188
Laura Kogelman, Md, MD
Infectious Disease — Payments: $114,676